Tokyo-1 aims to transcend corporate boundaries, empowering each research member to pursue innovation without being confined by traditional concepts or constraints. We are actively seeking dedicated individuals to join us in reshaping Japan’s pharmaceutical industry and pioneering the future. We are confident that participating in Tokyo-1 is a significant step towards revolutionary drug discovery, making a substantial impact on the future of healthcare.
Astellas Pharma Inc.
Category
Pharmaceutical Company
Interests
Astellas Pharma is pursuing innovative digital solutions across its business --- including in sales, manufacturing, and research and development --- to maximize outcomes for patients and reduce the costs of healthcare. With Tokyo-1, the company will accelerate its research with molecular simulations and large language models for generative AI. We will explore a wide range of applications including small molecule compounds, antibodies, gene therapy, cell therapy, targeted protein degradation, engineered phage therapy and mRNA medicine. By enabling us to take full advantage of recent advances in AI and simulation technology, we expect that Tokyo-1 will be one of the foundations on which Astellas can achieve its VISION for the future of pharmaceutical research.